Reperfusion therapy for minor stroke in China
Part of Brain & nervous system clinical trials.
This trial tests whether clot-busting drugs or mechanical clot removal given within 24 hours of a minor ischemic stroke is safe and effective. It aims to find the best way to restore blood flow to the brain for people with mild symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had little to no disability before this stroke (able to live independently).
- You have a confirmed ischemic stroke (a clot blocking blood flow in the brain) seen on a CT or MRI scan.
- You arrived at the hospital within 24 hours of stroke onset or the last time you were seen normal.
- Your stroke symptoms are mild (NIH stroke score of 5 or less).
- You are willing to receive standard medication, clot-busting drugs, or clot-removal procedures as part of the study.
- You or a legal representative have signed a consent form understanding the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a clot-busting drug called tenecteplase for patients having a mild stroke (with weakness on one side or trouble speaking) who can get treatment within 4.5 hours. The goal is to see if this drug helps improve blood flow and reduces disability.
This trial tests whether giving a clot-dissolving medication directly into the brain's blood vessels during a standard procedure (mechanical thrombectomy) can improve outcomes for people with a stroke caused by a blockage in a medium-sized artery. It may be an option for patients who arrive at the hospital within 24 hours of symptom onset and have enough salvageable brain tissue.
This trial tests a specialized clot-removal treatment for people who had a mild but disabling stroke up to 24 hours ago and have a large artery blockage in the brain. The goal is to see if this precision therapy can help reduce disability and improve recovery.
This trial tests whether emergency clot removal (endovascular therapy) can help people whose mild stroke gets worse within a week. It's for those who have a blockage in a large brain artery and enough healthy brain tissue to save.
This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.
This study is tracking patients in southwestern China who have had an acute ischemic stroke and received a clot-busting medicine through an IV. It aims to learn more about how well this treatment works and how it is used in real-world settings.
Hear when a new Minor Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.